The objective of the procurement is to enter into framework agreement for the delivery of HPV vaccine for the vaccination of women up to 26 years of age. The vaccination of this group is a one-off measure, with a duration of two years. Start up for the vaccination is anticipated to be August 2016.

Acquiring vaccination of 6 sets corresponds to offering vaccine to 6 x 30 000 women = 180 000 women.

There is uncertainty surrounding the number of doses as it is dependent on how many women choose to be vaccinated (vaccine coverage).

As a result of this, the volume of the framework agreement spans from 20 % of the estimated coverage to 45 % of the estimated coverage. With three doses per person, this is equivalent to a volume of approx. 108 000 (minimum) — 243 000 doses (maximum). In accordance with the contract, the Contracting Authority is obliged to purchase the minimum volume. Call offs beyond the minimum volume will be dependent on budget coverage and what vaccine coverage is achieved.